Benztropine 1 mg Tablets — Generic For Cogentin — Leading Pharma

Medication Summary

Medication Summary: This section summarizes DailyMed drug label information to make the label easier to understand. It is not a substitute for the official label, pharmacist counseling, prescriber instructions, or medical advice.

Overview

Benztropine mesylate tablets are prescription oral tablets that contain 0.5 mg, 1 mg, or 2 mg of benztropine mesylate. The product also contains inactive ingredients such as corn starch, dicalcium phosphate anhydrous, hydrogenated vegetable oil, lactose anhydrous, lactose monohydrate, microcrystalline cellulose, and talc.

The label states that benztropine mesylate has anticholinergic and antihistaminic effects, and that its anticholinergic effect is the one considered therapeutically significant in parkinsonism. It is used as an adjunct in the therapy of all forms of parkinsonism and can also be used to help control extrapyramidal disorders caused by neuroleptic drugs, except tardive dyskinesia.

The label includes warnings about possible drowsiness or impaired ability to do tasks like driving or operating machinery, as well as risks such as dry mouth, constipation, urinary retention, blurred vision, confusion, hallucinations, overheating, and decreased sweating. It should not be used in children under 3 years of age, and it should be used with caution in older pediatric patients and in certain other situations described on the label.

Storage Information

Store at 20° to 25° C (68° to 77°F); excursions permitted to 15° to 30° C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in well-closed containers as defined in the USP.

Key Counseling Points

• Take this medicine only as directed on the prescription label.
• The label says therapy is usually started at a low dose and increased gradually.
• Do not stop other antiparkinsonian medicines suddenly unless the prescriber tells you to.
• Be alert for dry mouth, constipation, blurred vision, urinary retention, or trouble swallowing.
• Report confusion, hallucinations, unusual excitement, or worsening mental symptoms promptly.
• Watch for signs of overheating, fever, or decreased sweating, especially in hot weather.
• Use caution with driving or operating machinery because the medicine may impair mental or physical abilities.
• Tell your healthcare professional if you have glaucoma, prostatic hypertrophy, or a tendency to fast heart rate, since the label says close observation may be needed.
• The label says to report side effects to the FDA or to Leading Pharma, LLC.

Helpful Patient Education

Benztropine mesylate tablets USP are oral tablets available in 0.5 mg, 1 mg, and 2 mg strengths. According to the DailyMed label, this medicine is used as an adjunct treatment for parkinsonism and may also help control certain extrapyramidal symptoms caused by neuroleptic drugs, except tardive dyskinesia.

Product labeling also describes important safety information, including possible anticholinergic side effects such as dry mouth, constipation, urinary retention, blurred vision, and overheating. This educational summary is based on DailyMed label information for benztropine mesylate tablets.

Medication Summary last generated: 2026-07-10 02:58:10